Ann Lab Med.  2017 Mar;37(2):172-173. 10.3343/alm.2017.37.2.172.

Colistin Resistance in Escherichia coli Isolates From Patients With Bloodstream Infection in Korea

• Kim YA
• Yong D
• Jeong SH
• Lee K

• KMID: 2373639
• DOI: http://doi.org/10.3343/alm.2017.37.2.172

Abstract

No abstract available.

MeSH Terms

Anti-Bacterial Agents/*pharmacology
Bacteremia/*diagnosis/microbiology
Colistin/*pharmacology
Drug Resistance, Bacterial
Escherichia coli/*drug effects/isolation & purification
Humans
Microbial Sensitivity Tests
Republic of Korea
Anti-Bacterial Agents
Colistin

Reference

1. Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006; 6:589–601. PMID: 16931410.

2. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016; 16:161–168. PMID: 26603172.

3. Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agersø Y, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill. 2015; 20(49):

4. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. 2016. Last visited on Nov 2016. http://www.eucast.org/clinical_breakpoints.

5. Bialvaei AZ, Samadi Kafil H. Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin. 2015; 31:707–721. PMID: 25697677.

6. Kang CI, Cha MC, Kim SH, Ko KS, Wi YM, Chung DR, et al. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period. J Korean Med Sci. 2013; 28:998–1004. PMID: 23853481.